By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Enzo Biochem announced after the close of the market on Monday that revenues during its fiscal first quarter rose a fraction of 1 percent and that it is developing two molecular diagnostic platforms as part of a strategy to move to "higher value products and systems directed at the non-academic market segment."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: rare variants linked to bleeding disorder, comparison of whole-exome and whole-genome sequencing, and more.

George Church tells The Sunday Times that his group has inserted some woolly mammoth genes into elephant cells.

A Scientific Reports editor resigns over a new policy at the journal allowing researchers to pay to fast track the peer review of their manuscripts, and poll.

The National Cancer Institute's Harold Varmus discusses the state of cancer research with the New York Times.